Current management and management controversies in early- and intermediate-stage of nonseminoma germ cell tumors

Early stage nonseminomatous germ cell tumor (NSGCT) remains a treatable disease, with stage I cancer specific survival exceeding 95%. Using a risk-adapted approach; active surveillance (AS), adjuvant chemotherapy, and retroperitoneal lymph node dissection (RPLND) all options for treatment; with surv...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Transl Androl Urol
Autors principals: Cheriyan, Salim K., Nicholson, Marilin, Aydin, Ahmet M., Azizi, Mounsif, Peyton, Charles C., Sexton, Wade J., Gilbert, Scott M.
Format: Artigo
Idioma:Inglês
Publicat: AME Publishing Company 2020
Matèries:
Review Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6995850/
https://ncbi.nlm.nih.gov/pubmed/32055485
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tau.2019.05.14
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars